Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Status:
Completed
Trial end date:
2016-07-11
Target enrollment:
Participant gender:
Summary
This study will evaluate flortaucipir for brain imaging of tau in subjects with progressive
supranuclear palsy (PSP), corticobasal degeneration (CBD) and healthy volunteers.